Status:
COMPLETED
Promoting the Use of CPAP Therapy Among OSA Patients
Lead Sponsor:
Sarah Alismail
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is the most common sleep breathing disorder in the U.S. Continuous Positive Airway Pressure (CPAP) therapy is the most effective treatment for OSA. However, up to 50% of ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of OSA
- Prescribed treatment of CPAP therapy
- Possession of a mobile phone that has multimedia messaging capabilities
- Capacity to consent.
Exclusion
- Unable to speak and read English
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04372329
Start Date
July 1 2020
End Date
September 30 2021
Last Update
August 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pomona Valley Hospital Medical Center Adults and Children Sleep Disorders Center
Claremont, California, United States, 91711